Navigation Links
Watson Announces Preliminary 2011 Non-GAAP Earnings of $4.75-$4.77
Date:1/24/2012

- Forecasted Adjusted EBITDA(Unaudited; in millions)Forecast for Twelve Months Ending December 31, 2012LowHighGAAP net income

$
315 $
354 Plus:Interest expense80 80 Interest income(1)(1)Provision for income taxes235 263 Depreciation (includes accelerated depreciation)20 20 Amortization470 470 EBITDA,219 ,286 Adjusted for:Global supply chain initiativeAcquisition and licensing charges20 20 Share-based compensation36 36 Adjusted EBITDA

$
,285.0 $
,352.0 The reconciliation table is based in part on management's estimate of adjusted EBITDA for the year ending December 31, 2012. Watson expects certain known GAAP charges for 2012 as presented in the schedule above. Other GAAP charges that may be excluded from estimated EBITDA are possible, but their amounts are dependent on numerous factors that we currently cannot ascertain with sufficient certainty or are presently unknown. These GAAP charges, such as potential asset impairment charges, are dependent upon future events and valuations that have not yet been performed.

CONTACTS:Investors:
Patty Eisenhaur
862-261-8141

Media:
Charlie Mayr
862-261-8030

(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO)


'/>"/>
SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Watson Acquires Ascent Pharmahealth for AU$375 Million
2. Watson to Present at the 30th Annual J.P. Morgan Healthcare Conference
3. Watson to Present at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top
4. Watson Launches Generic LoSEASONIQUE(R)
5. Watson Launches Generic LIPITOR®
6. Watson to Present at the 2011 Piper Jaffray Health Care Conference
7. Watson Wins Kentucky Drug Pricing Litigation
8. Watson Confirms Exelon(R) Patent Challenge
9. Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA
10. Watson Third Quarter 2011 Net Revenue Climbs 23% to $1.1 Billion; Non-GAAP Diluted EPS of $1.09; GAAP Diluted EPS of $0.54
11. Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Feb. 27, 2015 Securities lawyers at ... Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP ) in ... Concerned SLXP investors are encouraged to contact attorney Hamilton ... The investigation focuses upon the shareholder value of the ... would receive only $158.00 per share in cash. At ...
(Date:2/27/2015)... Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) today ... operating loss (NOL) guidance and its cash guidance ending ... improved financial results were due in large part to ... received from its partners.  Isis, pro forma NOL of ... over its 2013 NOL of $40.2 million. On a ...
(Date:2/27/2015)... VANCOUVER, Canada and HOUSTON, TX ... ("ESSA" or the "Company") (TSX-V: EPI) and Bloom Burton ... have released from voluntary contractual lock-up (the "Lock-Up") 2,353,130 ... of the Common Shares originally subject to the Lock-Up. ... shares will be free trading immediately upon release from ...
Breaking Medicine Technology:Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4
... published in the American Journal of Nephrology -, ... announced that its Phase III data on VAPRISOL was ... Nephrology. In this study,VAPRISOL showed a significant increase in ... life-threatening condition that,occurs when the body,s sodium level falls ...
... Cancer patients at Beaumont,Hospitals are the first in the ... therapy that is painless, faster, more accurate and precise,than ... patented the new,technology, Omnibeam(R). The $3.3-million machine is manufactured ... first patient,was treated on Sept. 10. The painless ...
Cached Medicine Technology:Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 2Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 3Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 4Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 5Beaumont Patients 1st to get Next Generation of Radiation Treatment 2
(Date:2/27/2015)... February 27, 2015 Over 440,000 patients die ... the equivalent of two jumbo jet airplanes crashing each day. ... band together in an effort to do all they can ... Dr. Richard Carmona, the 17th U.S. Surgeon General, discusses the ... to be able to address safety issues to ensure that ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Jupiter Medical ... pioneering partnership, Mount Sinai Heart New York at Jupiter ... research in South Florida. , “This innovative collaboration ... way we’re delivering unparalleled health care in our very ... Executive Officer of Jupiter Medical Center. “This kind of ...
(Date:2/27/2015)... Chicago, IL (PRWEB) February 27, 2015 ... Assistant Professor of Biomedical Engineering at Duke University, ... modification for boys and young men with Duchenne ... 18 in Nature Communications, and Gersbach will discuss ... be held March 11-14 in Washington, D.C. , ...
(Date:2/27/2015)... York, NY (PRWEB) February 27, 2015 Ticket ... Tickets for his "Forest Hills Drive Tour Act 3: ... album "2014 Forest Hills Drive" which debuted on the charts ... hip-hop album. In March, this accomplished hip-hop artist will ... in early March and will visit cities such as San ...
(Date:2/27/2015)... 2015 Over 440,000 patients die each year ... now to educate readers on how they can take control ... serve as a guide to educate and inspire readers to ... loved ones safe with tips on topics ranging from hospital ... cover of the print publication. He recently spoke to ...
Breaking Medicine News(10 mins):Health News:Dr. Richard Carmona, the 17th U.S. Surgeon General, and IntelliCentrics Raise Awareness in Mediaplanet’s “Patient Safety” Campaign 2Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 2Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 3Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 4Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 5Health News:Statement: New MDA-Funded Genetic Therapy Technique Targets DMD 2Health News:J. Cole Tickets in Los Angeles, Mountain View, Chula Vista, New York, Chicago, Indianapolis, Holmdel, Dallas, Seattle, Camden, Bristow, Atlanta, Houston & Detroit On Sale 2Health News:J. Cole Tickets in Los Angeles, Mountain View, Chula Vista, New York, Chicago, Indianapolis, Holmdel, Dallas, Seattle, Camden, Bristow, Atlanta, Houston & Detroit On Sale 3Health News:Safe and Sound: Improving Patient Outcomes through Mediaplanet’s “Patient Safety” Campaign 2
... entered into generic licensing deals with 10 Indian pharma ... to get a patent in India soon. ... access programme and licensed Indian pharmas to manufacture Viread ... for the pill," Gregg Alton, senior vice president and ...
... A concerted attempt is on in the US to rein ... the internet safer for everyone. ,Social networking ... and personal information, and let them send messages to one ... ,The hugely popular MySpace had initially balked when attorneys general ...
... curb a remorselessly exploding population, the government of China has ... time, like the one child norm. ,The policy ... at controlling population growth in the world's biggest nation with ... to have one child, while villagers can have two if ...
... claim to the highest autism rate in America, have pushed toward ... care for those with the disorder. A recent U.S. study of ... in 152 have the disorder, with the highest rate 1 ... , According to Madeleine Goldfarb, a Livingston mother of a 13-year-old ...
... impotence drug Viagra may be useful for treating jet ... treatment of high blood pressure and angina, works by ... naturally-occurring compound, cyclic guanine monophosphate (cGMP). ,In ... signalling pathway that regulates the circadian cycle, the body's ...
... yoga is not only good for the body, but ... brain, especially when it comes to keeping depression and ... University School of Medicine (BUSM) and McLean Hospital have ... levels, the brain's primary inhibitory neurotransmitter. ,Using ...
Cached Medicine News:Health News:Gilead's AIDS Drug Awaits Patent in India 2Health News:My Space Pressured into Sharing Data on Sex Offenders 2Health News:Aggressive Family Planning Sparks Riots in China 2Health News:American State Lawmakers Make Moves To Tackle Autism 2Health News:Yoga Helps to Combat Depression, Anxiety 2
Flexible rake retractor, 3 blunt prongs....
Rees bayonet forceps, standard, 5-1/2", TC....
... Implants, designed to accept rigid ... with an excellent reconstructive option ... floor blowout defects. Each design ... of one or more rigid ...
... Medpor Midface Rim is designed ... concavities of the midface, including ... malar. When positioned in the ... Medpor Midface Rim implant aids ...
Medicine Products: